📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment. (2024)

First Author: Augello M

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2024.126184

PubMed Identifier: 39097440

Publication URI: http://europepmc.org/abstract/MED/39097440

Type: Journal Article/Review

Volume: 42

Parent Publication: Vaccine

Issue: 25

ISSN: 0264-410X